Position in VYGR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$299,065
+$205,960 QoQ
Shares Held
77,478
+288.6% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $48,959,238 across 141 Biotechnology names. VYGR ranks #43 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
70,715 | $3,728,094 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,408,886 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
67,775 | $2,692,023 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
54,785 | $2,204,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,173,678 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
262,298 | $2,011,825 | |
| 7 | ANAB |
Anaptysbio, Inc
|
33,323 | $1,848,091 | |
| 8 | ABVX |
Abivax S.A.
|
9,551 | $1,063,503 |
All Filings in VYGR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $299,065 | 77,478 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $93,105 | 19,937 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $100,313 | 17,692 | Shares | Defined | 2025-02-11 | |
| 2023-06-30 | $318,939 | 27,855 | Shares | Defined | 2023-07-27 | |
| 2022-03-31 | $140,535 | 18,443 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $27,918 | 10,302 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||